new drug   CDRI's Contraceptive development programme has acieved anther great success in this area of national and international importance. It's contraceptive Cream, CONSAP has now been approved by the Drugs Controller General of India for its marketing and use. CONSAP is a sterile contraceptive cream developed from the saponins obtained from soap nuts (Reetha) collected from the plant Sapindus mukorosii. The cream is recommended for all women of reproductive age group who want to space their children. It is safe and free from systemic side effects on continuous prolonged use. The preparation has been developed by using saponins from the soapnut or reetha (Sapindus mukorossi). The cream went through all regulatory testing and Phase I, II and III clinical trials and proved to be an effective contraceptive product. DCGI has granted the Marketing premission.

The CONSAP Cream has been licensed to the Hindustan Latex Limited who are going to market the product in very near future.